Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > University of Texas at Austin Licenses Technology For Nanoparticle Detection to Houston Company

Abstract:
Technology that can determine the concentration of nanomaterials in living tissue has been licensed by The University of Texas at Austin to Houston-based nanoTox Inc.

The technology comes from the laboratory of Dr. James Tunnell, an assistant professor in the Department of Biomedical Engineering in the Cockrell School of Engineering. Tunnell's lab focuses on developing minimally invasive optical technologies for the detection, diagnosis and treatment of disease, particularly for application to cancer screening and therapeutics.

University of Texas at Austin Licenses Technology For Nanoparticle Detection to Houston Company

Austin, TX | Posted on September 29th, 2008

Nanoparticles are pure chemical or molecular materials smaller than one-tenth of a micrometer that are increasingly being used in a variety of applications, including medical devices, medicines and cosmetics.

In developing safe and effective products, one concern is knowing what becomes of nanoparticles applied or administered to the body. For example, nanoparticles designed to concentrate in certain locations such as tumor tissue for diagnostic or therapeutic purposes must not accumulate in other healthy tissues where they might cause harm such as the brain, heart, liver or kidneys.

Tunnell's tool, which employs optical spectroscopy, provides a non-invasive way for companies who use nanoparticles in their products to tell whether those particles remain in tissue or have been flushed out.

"This uses an optical fiber that you just place in contact with the tissue and the light makes a measurement in a non-invasive way," Tunnell said.

The current method for measuring nanoparticles at diagnostic or therapeutic concentrations in tissue typically involves the administration of radioisotopes or invasive procedures requiring a biopsy followed by time-consuming and costly examination using specialized forms of electron microscopy, X-ray analysis or nuclear chemical analysis in some cases.

"Dr. Tunnell has created a very minimally invasive technique to detect nanoparticles in tissue relatively simply and economically," said Greg King, vice president and chief operating officer of nanoTox®.

As a detection tool, it "will answer a lot of questions that government agencies and consumers are asking about nanomaterials," Harry Bushong, the company's president, said.

The license grants nanoTox® exclusive worldwide rights to the technology which includes the development of medical diagnostic applications. The company also plans to further develop the technology for other uses such as the nanotechnology risk-assessment market.

Nanotox has laboratory and research operations in Austin.

The company's chief scientific officer, Dr. David Hobson, said that working with Tunnell and his laboratory staff should lead to the development of this promising technology into a valuable tool for medical and nanotechnology safety assessment applications.

Understanding the risks from exposure to nanomaterials helps to satisfy international product liability insurers that support the development of beneficial applications of nanotechnology.

The company's scientists consult with engineers, chemists and other nanomaterial developers to identify and either eliminate or reduce significant toxicity found in a nanomaterial, thereby improving the safety of nanomaterials for customers, employees and the environment.

####

For more information, please click here

Contacts:
Tim Green
Office of the Vice President for Research
512-475-6596


Bill Stahl
nanoTox Inc.
512-804-2800

Copyright © University of Texas at Austin

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related Links

Biophotonics Laboratory

Department of Biomedical Engineering

Office of Technology Commercialization

nanoTox Inc.

Related News Press

News and information

Study reveals how herpes virus tricks the immune system February 5th, 2016

Hepatitis virus-like particles as potential cancer treatment February 5th, 2016

Organic crystals allow creating flexible electronic devices: The researchers from the Faculty of Physics of the Moscow State University have grown organic crystals that allow creating flexible electronic devices February 5th, 2016

Researchers discover new phase of boron nitride and a new way to create pure c-BN February 5th, 2016

Nanomedicine

Study reveals how herpes virus tricks the immune system February 5th, 2016

Hepatitis virus-like particles as potential cancer treatment February 5th, 2016

Researchers discover new phase of boron nitride and a new way to create pure c-BN February 5th, 2016

Nanoparticles Make Fertility Possible during Consumption of Anticancer Drugs February 4th, 2016

Announcements

Study reveals how herpes virus tricks the immune system February 5th, 2016

Hepatitis virus-like particles as potential cancer treatment February 5th, 2016

Organic crystals allow creating flexible electronic devices: The researchers from the Faculty of Physics of the Moscow State University have grown organic crystals that allow creating flexible electronic devices February 5th, 2016

Researchers discover new phase of boron nitride and a new way to create pure c-BN February 5th, 2016

Patents/IP/Tech Transfer/Licensing

Joint Efforts by Iranian, Malaysian Scientists Produce Antibacterial Coatings for Isolated Areas February 4th, 2016

Silicon-based metamaterials could bring photonic circuits February 1st, 2016

Therapeutic Solutions International Licenses Dexosome Clinical Stage Cancer Immunotherapy Product From Gustave Roussy European Cancer Centre: FDA Cleared Immuno-Oncology Technology to Resume Clinical Development for Solid Tumor Patients January 27th, 2016

Light-activated nanoparticles prove effective against antibiotic-resistant 'superbugs' January 19th, 2016

Safety-Nanoparticles/Risk management

Are some people more likely to develop adverse reactions to nanoparticle-based medicines? January 31st, 2016

Too-few proteins prompt nanoparticles to clump: Rice scientists: Blood serum proteins must find balance with therapeutic nanoparticles January 29th, 2016

FLEXcon shares insights on developments and safety guidelines in nanotechnology: FLEXcon hosted New England Nanotechnology Association event, discussing latest industry activities and innovations January 25th, 2016

Louisiana Tech University student coauthors research in ACS journal January 15th, 2016

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







Car Brands
Buy website traffic